DrugPatentWatch Database Preview

SODIUM THIOSULFATE Drug Profile

  Purchase this report

or, see our see our flat-rate plans

« Back to Dashboard

When do Sodium Thiosulfate patents expire, and when can generic versions of Sodium Thiosulfate launch?

Sodium Thiosulfate is a drug marketed by Us Army and Hope Pharms and is included in two NDAs. There are three patents protecting this drug.

This drug has fifteen patent family members in eight countries.

The generic ingredient in SODIUM THIOSULFATE is sodium thiosulfate. There are one thousand four hundred and twenty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium thiosulfate profile page.

Summary for SODIUM THIOSULFATE

International Patents:	15
US Patents:	3
Applicants:	2
NDAs:	2
Suppliers / Packagers:	1
Bulk Api Vendors:	54
Clinical Trials:	2,431
Patent Applications:	2,217
Formulation / Manufacturing:	see details
DailyMed Link:	SODIUM THIOSULFATE at DailyMed

Synonyms for SODIUM THIOSULFATE

10102-17-7 (pentahydrate)

1374442-73-5

13773-27-8

220945-47-1

7772-98-7

AC1L2NGO

AC1Q1USN

ACMC-1BLMJ

AI3-01237

AKHNMLFCWUSKQB-UHFFFAOYSA-L

AKOS015856704

AKOS016372312

anhydrous sodium thiosulfate

BP-21059

CHEBI:132112

CHEMBL3753202

Chlorine Control

Chlorine Cure

CTK2H7219

D0P9NT

Declor-It

Detoxol

disodium sulfurothioate

Disodium thiosulfate

DTXSID9042417

EC 231-867-5

EINECS 231-867-5

FT-0696570

HSDB 592

Hypo

Hypo (VAN)

Hypo alcohol

Hypo alcohol, in ethanol

Hyposulphite of soda

I14-16584

KS-00000VC8

KSC377E1T

L0IYT1O31N

LS-153406

LT03329071

MFCD00003499

MolPort-003-926-155

MolPort-006-118-733

Na2O3S2

Na2S2O3

NSC 45624

RP22166

RTR-031296

SC-74795

Sodium oxide sulfide

Sodium oxide sulfide (Na2S2O3)

sodium thio-sulfate

sodium thiosulfat

sodium thiosulfate (anhydrous)

Sodium thiosulfate (Na2S2O3)

Sodium thiosulfate 2.5M solution

Sodium thiosulfate anhydrous

Sodium thiosulfate concentrate

Sodium thiosulfate solution, 0.01 M

Sodium thiosulfate solution, 0.025 M

Sodium thiosulfate solution, 0.1 M

Sodium thiosulfate solution, 1 M

Sodium thiosulfate solution, 2 g/dL in deionized water

Sodium thiosulfate solution, Silver stain kit component, 0.5 % (w/v) sodium thiosulfate in H2O

Sodium thiosulfate, >=99.99% trace metals basis

Sodium thiosulfate, anhydrous

Sodium thiosulfate, anhydrous, >=98% (calc. to the dried substance)

Sodium thiosulfate, AR, >=98%

Sodium thiosulfate, LR, >=97%

Sodium thiosulfate, p.a., 98.0%

Sodium thiosulfate, purum p.a., anhydrous, >=98.0% (RT)

Sodium thiosulfate, ReagentPlus(R), 99%

Sodium thiosulfate, SAJ first grade, >=90.0%

Sodium thiosulfate, Vetec(TM) reagent grade, 99%

Sodium thiosulfate,anhydrous

Sodium thiosulphate

Sodium thiosulphate (Na2S2O3)

sodiumthiosulfate

Thiosulfuric acid (H2S2O3) disodium salt

Thiosulfuric acid (H2S2O3), disodium salt

Thiosulfuric acid (H2S2O3), sodium salt (1:2)

Thiosulfuric acid, disodium salt

TR-031296

TRA0058020

UNII-L0IYT1O31N

X5843

US Patents and Regulatory Information for SODIUM THIOSULFATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Us Army	SODIUM THIOSULFATE	sodium thiosulfate	INJECTABLE;INJECTION	020166-001	Feb 14, 1992		DISCN	No	No
Hope Pharms	SODIUM THIOSULFATE	sodium thiosulfate	SOLUTION;INTRAVENOUS	203923-001	Feb 14, 2012		RX	Yes	Yes			Y	Y
Hope Pharms	SODIUM THIOSULFATE	sodium thiosulfate	SOLUTION;INTRAVENOUS	203923-001	Feb 14, 2012		RX	Yes	Yes			Y	Y
Hope Pharms	SODIUM THIOSULFATE	sodium thiosulfate	SOLUTION;INTRAVENOUS	203923-001	Feb 14, 2012		RX	Yes	Yes			Y	Y

  Purchase this report

or, see our see our flat-rate plans

Non-Orange Book US Patents for SODIUM THIOSULFATE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
9,579,345	Sodium thiosulfate-containing pharmaceutical compositions
8,715,746	Sodium thiosulfate-containing pharmaceutical compositions
9,144,580	Sodium thiosulfate-containing pharmaceutical compositions

  Purchase this report

or, see our see our flat-rate plans

International Patents for SODIUM THIOSULFATE

Country	Document Number	Estimated Expiration
Japan	2017165758
Canada	2767168
Denmark	2451435
Japan	6182622

Supplementary Protection Certificates for SODIUM THIOSULFATE

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
90062-5	Sweden		PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
90064-1	Sweden		PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
C0022	France		PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825
C/GB02/042	United Kingdom		PRODUCT NAME: ERTAPENEM ((1R,5S,6S,8R,2'S,4'S)-2-(2-(3-CARBOXYPHENYLCARBAMOYL)PYRROLIDIN-4-YLTHIO)-6-(1-HYDROXYETHYL)-1-METHYLCARBAPENEM-3-CARBOXYLIC ACID), A PHARMACEUTICALLY ACCEPTABLE SALT OR IN VIVO HYDROLYSABLE ESTER THEREOF, ESPECIALLY AS THE MONOSODIUM SALT ERTA; REGISTERED: UK EU/1/02/216/001 20020422